Chemours (CC) financials
Chemours revenue and earnings by year
Chemours's revenue was $5.81 billion in the fiscal year to December 31, 2025, up 0.4% from the year before. Net income was -$386 million, -6.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 0.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.81 | 5.78 | 6.08 | 6.83 | 6.35 | 4.97 | 5.53 | 6.64 | 6.18 | 5.40 |
| Revenue growth | 0.4% | -4.9% | -11.0% | 7.7% | 27.7% | -10.1% | -16.8% | 7.4% | 14.5% | — |
| Gross profit | 0.90 | 1.14 | 1.30 | 1.62 | 1.38 | 1.07 | 1.06 | 1.97 | 1.75 | 1.10 |
| Gross margin | 15.5% | 19.8% | 21.4% | 23.7% | 21.8% | 21.5% | 19.2% | 29.7% | 28.2% | 20.4% |
| Operating income | -0.06 | 0.32 | -0.25 | 0.77 | 0.68 | 0.37 | 0.35 | 1.18 | 0.98 | -0.09 |
| Operating margin | -1.1% | 5.5% | -4.0% | 11.3% | 10.7% | 7.4% | 6.3% | 17.8% | 15.9% | -1.7% |
| Net income | -0.39 | 0.07 | -0.25 | 0.58 | 0.61 | 0.22 | -0.05 | 1.00 | 0.75 | 0.01 |
| Net margin | -6.6% | 1.2% | -4.2% | 8.5% | 9.6% | 4.4% | -0.9% | 15.0% | 12.1% | 0.1% |
| Diluted EPS | -$2.56 | $0.45 | -$1.60 | $3.56 | $3.60 | $1.32 | -$0.36 | $5.43 | $3.90 | $0.03 |
| Free cash flow | 0.05 | -0.99 | 0.19 | 0.45 | 0.54 | 0.54 | 0.17 | 0.64 | 0.23 | 0.26 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CC in Markets.
How Chemours makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Titanium Technologies | $661M | 41.5% |
| Thermal & Specialized Solutions | $591M | 37.1% |
| Advanced Performance Materials | $326M | 20.5% |
| Other Non Reportable | $13.0M | 0.8% |
See also: CC valuation and P/E history · CC returns
No forecast, no recommendation. This page describes Chemours from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.